anmeldenSXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.10.12 | Novartis buy | Deutsche Bank AG | |
| 11.10.12 | Novartis buy | UBS AG | |
| 10.10.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 08.10.12 | Novartis reduce | Vontobel Research | |
| 05.10.12 | Lonza hold | Vontobel Research | |
| 05.10.12 | Sonova neutral | Sarasin Research | |
| 05.10.12 | Straumann hold | Vontobel Research | |
| 05.10.12 | Sonova buy | Vontobel Research | |
| 04.10.12 | Novartis buy | Nomura | |
| 02.10.12 | Tecan (N) neutral | Sarasin Research | |
| 01.10.12 | Novartis buy | Sarasin Research | |
| 01.10.12 | Novartis reduce | Vontobel Research | |
| 27.09.12 | Sonova neutral | Sarasin Research | |
| 27.09.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 24.09.12 | Novartis reduce | Vontobel Research | |
| 24.09.12 | Novartis buy | Sarasin Research | |
| 14.09.12 | Lonza neutral | J.P. Morgan Cazenove | |
| 13.09.12 | Novartis reduce | Vontobel Research | |
| 12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 11.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 11.09.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 11.09.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 10.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 05.09.12 | Novartis reduce | Vontobel Research | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.09.12 | Novartis reduce | Vontobel Research | |
| 03.09.12 | Novartis kaufen | Die Actien-Börse | |
| 31.08.12 | Novartis buy | Deutsche Bank AG | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis buy | Sarasin Research | |
| 30.08.12 | Novartis reduce | Vontobel Research | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
| 28.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
| 27.08.12 | Novartis reduce | Vontobel Research | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA |
